Free · no account · quoted from the filing

What changed in EMR's 10-Q

Source: 10-Q filed 2026-05-05 · compared against 10-Q 2026-02-03. Every passage below is quoted verbatim from the filing itself.

Guidance

This filing

consolidated net sales are expected to be up approximately 4.5 percent, with underlying sales up approximately 3 percent

Risk factors

This filing

the scope, duration and ultimate impacts of the Russia-Ukraine, Middle East and other global conflicts

Demand

This filing

Underlying sales were up 0.5 percent on 3.5 percent higher price, offset by 3 percent lower volume due to a negative impact of 2 percent related to the timing of software renewals and 1 percent related to the conflict in the Middle East

Legal

This filing

In February 2026, the U.S. Supreme Court ruled that the International Emergency P

Liquidity

This filing

364-Day Credit Agreement dated as of February 10, 2026

Segments

This filing

Safety & Productivity sales were up 5 percent

What it means — the analyst reading

The passages above are the company's own words. The plain-English reading of them — what changed, why it matters, and the direction of travel — is part of the Filing Change Monitor.

See the Filing Change Monitor →

Compared from narrative excerpts (outlook, risks, MD&A) of both filings — quotes are verbatim from the new filing. Not advice. Source: company SEC filings via stockportfolio.pro. Educational, not investment advice.